First Manhattan CO. LLC. Sells 2,537 Shares of Agilent Technologies, Inc. $A

Key Points

• First Manhattan CO. LLC. reduced its stake in Agilent Technologies by 3.1%, holding 79,375 shares valued at approximately $9.29 million as of its latest SEC filing.
• CEO Padraig Mcdonnell sold 1,508 shares of Agilent stock for over $177,000, representing a 3.87% reduction in his ownership.
• Wall Street analysts project growth for Agilent Technologies, with target prices ranging from $135.00 to $155.00 and a consensus rating of "Moderate Buy".

First Manhattan CO. LLC. lessened its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 3.1% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 79,375 shares of the medical research company's stock after selling 2,537 shares during the period. First Manhattan CO. LLC.'s holdings in Agilent Technologies were worth $9,285,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the business. Sunbelt Securities Inc. grew its position in shares of Agilent Technologies by 640.0% during the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock valued at $30,000 after purchasing an additional 192 shares in the last quarter. Whipplewood Advisors LLC grew its position in shares of Agilent Technologies by 286.2% during the first quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock valued at $29,000 after purchasing an additional 186 shares in the last quarter. Wood Tarver Financial Group LLC purchased a new position in shares of Agilent Technologies during the fourth quarter valued at about $34,000. Stone House Investment Management LLC purchased a new position in shares of Agilent Technologies during the first quarter valued at about $30,000. Finally, Opal Wealth Advisors LLC purchased a new position in shares of Agilent Technologies during the first quarter valued at about $31,000.

Agilent Technologies Trading Up 0.2%

A traded up $0.21 on Friday, hitting $128.69. The company had a trading volume of 1,633,203 shares, compared to its average volume of 1,522,644. The company has a market cap of $36.48 billion, a PE ratio of 30.21, a PEG ratio of 4.00 and a beta of 1.24. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The business's fifty day simple moving average is $119.22 and its 200 day simple moving average is $116.34.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting the consensus estimate of $1.37. The company had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm's revenue was up 10.1% on a year-over-year basis. During the same quarter last year, the business posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on A shares. Leerink Partners raised their price objective on Agilent Technologies to $135.00 and gave the company a "buy" rating in a research report on Friday, May 30th. TD Cowen raised their price objective on Agilent Technologies to $150.00 and gave the company a "buy" rating in a research report on Thursday, May 29th. Wells Fargo & Company raised their price objective on Agilent Technologies from $135.00 to $140.00 and gave the company an "overweight" rating in a research report on Thursday, August 28th. Robert W. Baird raised their price objective on Agilent Technologies from $141.00 to $142.00 and gave the company an "outperform" rating in a research report on Thursday, August 28th. Finally, Wall Street Zen lowered Agilent Technologies from a "buy" rating to a "hold" rating in a research report on Friday. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $139.25.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the firm's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the sale, the chief executive officer owned 37,448 shares of the company's stock, valued at $4,397,893.12. This trade represents a 3.87% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.